Introduction
Manganese chloride (MnCl 2 ) rapidly releases free Mn 2+ in the blood allowing for its active intracellular uptake by myocytes thus making it a potentially ideal candidate for perfusion and viability studies of the myocardium. However, MnCl 2 toxicity might reduce the clinical effectiveness of the substance as a contrast agent. Therefore, we designed this study to investigate for the first time in humans the safety and efficacy of a rapid infusion of MnCl 2 for cardiovascular magnetic resonance (CMR) imaging.
Methods
Fifteen normal volunteers underwent a CMR exam on a commercial 1.5 T scanner. Before the infusion, evaluation of cardiac function was performed with a short axis midventricular slice being chosen for the signal intensity stud-ies. Images of this slice were obtained using a 2D and 3D gradient-echo inversion recovery (GRE-IR) sequence, a phase-sensitive IR sequence and a single breath-hold segmented IR prepared steady-state precession acquisition for T 1 calculations. MnCl 2 was infused in three minutes at a total dose of 5 μMol/kg. Immediately after the infusion, at 15 and 30 minutes new images were obtained and cardiac function was re-evaluated.
Results
There was a significant decrease in T 1 values compared to baseline, sustained up to 30 minutes after the MnCl 2 infusion (Table 1) . The 2D GRE-IR sequence showed the greatest relative increase in signal intensity compared to the other sequences (Figure 1 ). There was a slight increase in systolic pressure and heart rate after three and four minutes of the infusion with normalization of these parame- 
Conclusion
In the short term, MnCl 2 appears safe for human use. It effectively decreases myocardium T 1 , maintaining this effect for a relatively long period of time and allowing for the development of new imaging strategies in CMR. 
